Intervention News

Inari Medical has issued a recall and update to the instructions for use of its 30 mm thrombectomy catheter due to risk for injury and death from device entrapment and pulmonary emboli.

Revascularization of carotid arteries has always been a challenging procedure, and both carotid surgery and transfemoral carotid stenting can lead to severe complications.

Compared with 2019, in 2020, the first year of the COVID-19 pandemic, hospitalizations for acute MI were down but in-hospital mortality in that population rose in the U.S., researchers reported in the Korean Circulation Journal.

Text messages delivered to patients’ smartwatches show promise to improve physical activity for those undergoing cardiac rehabilitation, but sustained behavioral change over time may remain a challenge, researchers reported.

Teleflex announced its percutaneous transluminal coronary angioplasty perfusion balloon catheter has received FDA 510(k) clearance for balloon dilatation of coronary artery or coronary bypass graft stenoses.

High-quality CT and stress testing should be able to effectively and safely diagnose patients with stable chest pain and suspected CAD, regardless of BMI, while improving clinical efficiency, researchers reported.

Risk for psychiatric disorder or suicide attempt is particularly high in the first year following hospitalization for heart disease, and patient support is important to lower such risk, researchers reported.

For the 30th straight year, Cleveland Clinic topped U.S. News & World Report’s Best Hospitals rankings for cardiology and heart surgery.

Elixir Medical announced its novel sirolimus-eluting coronary implant adaptable to vessel physiology was granted a breakthrough device designation by the FDA.

Royal Philips announced the FDA 510(k) clearance and launch of image-guided therapy mobile C-arm system designed for complex vascular needs and clinical procedures such as cardiac interventions, pain management and urology.